Why the study?
Lactate, the end-product of glycolysis, was historically overlooked but has recently been identified to play major biological and pathophysiological roles in cardiovascular diseases.
What is the role of lactate in the pathophysiological process of cardiovascular diseases?
What is the role of lactate in the pathophysiological process of cardiovascular diseases?
This review highlights the emerging recognition of lactate's biological functions in cardiovascular diseases and its potential as a therapeutic target.
Answers are grounded in this paper and cite their sources.
Targeting lactate pathways remains strictly experimental with no current clinical application; leaves open whether modulating these mechanisms will.
Cardiovascular diseases pose a major threat worldwide. Common cardiovascular diseases include acute myocardial infarction (AMI), heart failure, atrial fibrillation (AF) and atherosclerosis. Glycolysis process often has changed during these cardiovascular diseases. Lactate, the end-product of glycolysis, has been overlooked in the past but has gradually been identified to play major biological functions in recent years. Similarly, the role of lactate in cardiovascular disease is gradually being recognized. Targeting lactate production, regulating lactate transport, and modulating circulating lactate levels may serve as potential strategies for the treatment of cardiovascular diseases in the future. The purpose of this review is to integrate relevant clinical and basic research on the role of lactate in the pathophysiological process of cardiovascular disease in recent years to clarify the important role of lactate in cardiovascular disease and to guide further studies exploring the role of lactate in cardiovascular and other diseases. Video Abstract.
No takes yet. Share an insight, caveat, or question.
Ouyang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: